Search Page

1

Cite

Share

Targeting T-cell migration in inflammatory bowel disease.

Marsal J, Agace WW. Marsal J, et al. J Intern Med. 2012 Nov;272(5):411-29. doi: 10.1111/j.1365-2796.2012.02588.x. Epub 2012 Oct 15. J Intern Med. 2012. PMID: 22946654 Review.

Cite

Share

2

Cite

Share

CCL25 mediates the localization of recently activated CD8alphabeta(+) lymphocytes to the small-intestinal mucosa.

Svensson M, Marsal J, Ericsson A, Carramolino L, Brodén T, Márquez G, Agace WW. Svensson M, et al. Among authors: marsal j. J Clin Invest. 2002 Oct;110(8):1113-21. doi: 10.1172/JCI15988. J Clin Invest. 2002. PMID: 12393847 Free PMC article.

Cite

Share

3

Cite

Share

beta1 integrins are not required for the maintenance of lymphocytes within intestinal epithelia.

Marsal J, Brakebusch C, Bungartz G, Fässler R, Agace WW. Marsal J, et al. Eur J Immunol. 2005 Jun;35(6):1805-11. doi: 10.1002/eji.200425941. Eur J Immunol. 2005. PMID: 15884052

Cite

Share

4

Cite

Share

Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intestine.

Stenstad H, Ericsson A, Johansson-Lindbom B, Svensson M, Marsal J, Mack M, Picarella D, Soler D, Marquez G, Briskin M, Agace WW. Stenstad H, et al. Among authors: marsal j. Blood. 2006 May 1;107(9):3447-54. doi: 10.1182/blood-2005-07-2860. Epub 2006 Jan 3. Blood. 2006. PMID: 16391017

Cite

Share

5

Cite

Share

IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation.

Persson EK, Uronen-Hansson H, Semmrich M, Rivollier A, Hägerbrand K, Marsal J, Gudjonsson S, Håkansson U, Reizis B, Kotarsky K, Agace WW. Persson EK, et al. Among authors: marsal j. Immunity. 2013 May 23;38(5):958-69. doi: 10.1016/j.immuni.2013.03.009. Epub 2013 May 9. Immunity. 2013. PMID: 23664832

Cite

Share

6

Cite

Share

A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionality.

Holmkvist P, Roepstorff K, Uronen-Hansson H, Sandén C, Gudjonsson S, Patschan O, Grip O, Marsal J, Schmidtchen A, Hornum L, Erjefält JS, Håkansson K, Agace WW. Holmkvist P, et al. Among authors: marsal j. Mucosal Immunol. 2015 May;8(3):545-58. doi: 10.1038/mi.2014.87. Epub 2014 Oct 1. Mucosal Immunol. 2015. PMID: 25269704 Free PMC article.

Cite

Share

7

Cite

Share

CD8αβ+ γδ T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease.

Kadivar M, Petersson J, Svensson L, Marsal J. Kadivar M, et al. Among authors: marsal j. J Immunol. 2016 Dec 15;197(12):4584-4592. doi: 10.4049/jimmunol.1601146. Epub 2016 Nov 14. J Immunol. 2016. PMID: 27849165

Cite

Share

8

Cite

Share

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis.

Bergqvist V, Hertervig E, Gedeon P, Kopljar M, Griph H, Kinhult S, Carneiro A, Marsal J. Bergqvist V, et al. Among authors: marsal j. Cancer Immunol Immunother. 2017 May;66(5):581-592. doi: 10.1007/s00262-017-1962-6. Epub 2017 Feb 15. Cancer Immunol Immunother. 2017. PMID: 28204866 Free PMC article.

Cite

Share

9

Cite

Share

Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).

Eriksson C, Marsal J, Bergemalm D, Vigren L, Björk J, Eberhardson M, Karling P, Söderman C; SWIBREG Vedolizumab Study Group, Myrelid P, Cao Y, Sjöberg D, Thörn M, Karlén P, Hertervig E, Strid H, Ludvigsson JF, Almer S, Halfvarson J. Eriksson C, et al. Among authors: marsal j. Scand J Gastroenterol. 2017 Jun-Jul;52(6-7):722-729. doi: 10.1080/00365521.2017.1304987. Epub 2017 Mar 31. Scand J Gastroenterol. 2017. PMID: 28362144

Cite

Share

10

Cite

Share

Colorectal cancer-infiltrating T lymphocytes display a distinct chemokine receptor expression profile.

Löfroos AB, Kadivar M, Resic Lindehammer S, Marsal J. Löfroos AB, et al. Among authors: marsal j. Eur J Med Res. 2017 Oct 11;22(1):40. doi: 10.1186/s40001-017-0283-8. Eur J Med Res. 2017. PMID: 29020986 Free PMC article.

Cite

Share